Trial Profile
Phase II trial of taladegib in advanced basal cell carcinoma
Status:
Planning
Phase of Trial:
Phase II
Latest Information Update: 13 Jan 2016
Price :
$35
*
At a glance
- Drugs Taladegib (Primary)
- Indications Basal cell cancer
- Focus Therapeutic Use
- 13 Jan 2016 New trial record